ES8704162A1 - Un procedimiento para preparar oxadiazolil-1,4-dihidropiri- dinas y sus compuestos analogos - Google Patents

Un procedimiento para preparar oxadiazolil-1,4-dihidropiri- dinas y sus compuestos analogos

Info

Publication number
ES8704162A1
ES8704162A1 ES85547724A ES547724A ES8704162A1 ES 8704162 A1 ES8704162 A1 ES 8704162A1 ES 85547724 A ES85547724 A ES 85547724A ES 547724 A ES547724 A ES 547724A ES 8704162 A1 ES8704162 A1 ES 8704162A1
Authority
ES
Spain
Prior art keywords
thiadiazolyl derivatives
novel oxa
oxa
novel
thiadiazolyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES85547724A
Other languages
English (en)
Other versions
ES547724A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharmaceuticals Co Ltd
Original Assignee
Sumitomo Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceuticals Co Ltd filed Critical Sumitomo Pharmaceuticals Co Ltd
Publication of ES8704162A1 publication Critical patent/ES8704162A1/es
Publication of ES547724A0 publication Critical patent/ES547724A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION OXADIAZOLIL-1,4-DIHIDROPIRIDINAS Y SUS COMPUESTOS ANALOGOS, DE FORMULA GENERAL (I), Y SUS SALES DE ADICION DE ACIDO FARMACEUTICAMENTE ACEPTABLES. CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA GENERAL (II), EN LA QUE A Y B, UNO DE ELLOS ES NITROGENO Y EL OTRO ES CARBONO; T2 ES CARBONILO O ALQUILENO INFERIOR; Y R2 ES FENILO O FENOXI, CON UN ALDEHIDO DE FORMULA: R13-CHO Y CON UNA ENAMINA DE FORMULA GENERAL (III). LA REACCION SE LLEVA A CABO EN UN DISOLVENTE INERTE Y A UNA TEMPERATURA COMPRENDIDA ENTRE LA AMBIENTE Y 15 GRADOS. DE APLICACION EN EL TRATAMIENTO DE LA ISQUEMIA DE MIOCARDIO, INFARTO E HIPERTENSION.
ES85547724A 1984-10-11 1985-10-09 Un procedimiento para preparar oxadiazolil-1,4-dihidropiri- dinas y sus compuestos analogos Expired ES8704162A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59213786A JPS6191185A (ja) 1984-10-11 1984-10-11 新規なオキサジアゾリル−１，４−ジヒドロピリジン誘導体

Publications (2)

Publication Number Publication Date
ES8704162A1 true ES8704162A1 (es) 1987-03-16
ES547724A0 ES547724A0 (es) 1987-03-16

Family

ID=16645021

Family Applications (2)

Application Number Title Priority Date Filing Date
ES85547724A Expired ES8704162A1 (es) 1984-10-11 1985-10-09 Un procedimiento para preparar oxadiazolil-1,4-dihidropiri- dinas y sus compuestos analogos
ES557234A Expired ES8900164A1 (es) 1984-10-11 1986-12-01 Un procedimiento para preparar oxadiazolil 1-4-dihidropiridinas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES557234A Expired ES8900164A1 (es) 1984-10-11 1986-12-01 Un procedimiento para preparar oxadiazolil 1-4-dihidropiridinas.

Country Status (8)

Country Link
US (1) US4705786A (es)
EP (1) EP0177965B1 (es)
JP (1) JPS6191185A (es)
KR (1) KR920008819B1 (es)
AT (1) ATE51229T1 (es)
CA (1) CA1326851C (es)
DE (1) DE3576689D1 (es)
ES (2) ES8704162A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3443179A1 (de) * 1984-11-27 1986-05-28 Cassella Ag, 6000 Frankfurt 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders
US4868181A (en) * 1986-08-04 1989-09-19 E. I. Du Pont De Nemours And Company 1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity
GB8830226D0 (en) * 1988-12-23 1989-02-22 Beecham Group Plc Novel compounds
US5276150A (en) * 1989-05-31 1994-01-04 Fujirebio Inc. 1,4-dihydropyridine derivatives
US5670526A (en) * 1995-12-21 1997-09-23 Otsuka Pharmaceutical Co., Ltd. 1,3,4-oxadiazoles
ZA9810320B (en) 1997-11-14 2000-05-11 Gea Farmaceutisk Fabrik As Process for the preparation of 1,4-dihydropyridines and novel compounds of use for such purpose.
DE102006044696A1 (de) 2006-09-22 2008-03-27 Bayer Healthcare Ag 3-Cyano-5-thiazaheteroaryl-dihydropyridine und ihre Verwendung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
JPS58150576A (ja) * 1982-03-03 1983-09-07 Sumitomo Chem Co Ltd 新規な１，２，４−オキサジアゾ−ル誘導体
US4414213A (en) * 1982-03-22 1983-11-08 Mead Johnson & Company Dihydropyridyl cyclic imidate esters and their pharmaceutical use
DE3247118A1 (de) * 1982-12-20 1984-06-20 Cassella Ag, 6000 Frankfurt Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3431152A1 (de) * 1984-08-24 1986-03-06 Cassella Ag, 6000 Frankfurt Verfahren zur herstellung optisch aktiver, substituierter 1,4-dihydropyridine und ihre verwendung als arzneimittel
DE3443179A1 (de) * 1984-11-27 1986-05-28 Cassella Ag, 6000 Frankfurt 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
KR920008819B1 (ko) 1992-10-09
KR860003244A (ko) 1986-05-21
EP0177965A3 (en) 1987-08-19
US4705786A (en) 1987-11-10
EP0177965B1 (en) 1990-03-21
ES547724A0 (es) 1987-03-16
DE3576689D1 (de) 1990-04-26
CA1326851C (en) 1994-02-08
JPS6191185A (ja) 1986-05-09
ES557234A0 (es) 1989-03-01
EP0177965A2 (en) 1986-04-16
JPH0255433B2 (es) 1990-11-27
ES8900164A1 (es) 1989-03-01
ATE51229T1 (de) 1990-04-15

Similar Documents

Publication Publication Date Title
ATE112963T1 (de) Gewebeentzusammensetzung und verfahren.
GB2194237B (en) 1,2,2,6, 6-pentamethyl-4-piperidylaminotriazine derivatives and their use as stabilizers
JPS6470422A (en) Manufacture of 1,4 butanediol and/or tetrahydrofuran
DK131787A (da) 1,1-disubstituerede cyclopropanderivater, deres fremstilling og anvendelse
GB2156806B (en) Production of diphenylamines or n,n'-diphenyl-phenylenediamines
DE3789530T2 (de) Klonierung und Expression des sauren Fibroblastenwachstumsfaktors.
EP0260121A3 (en) Inosose derivatives, production and use thereof
ES8704162A1 (es) Un procedimiento para preparar oxadiazolil-1,4-dihidropiri- dinas y sus compuestos analogos
EP0273800A3 (en) Hirudine variants, their use and preparation
MY107449A (en) Bcrf1 proteins as inhibitors of interferon- gamma.
NZ218856A (en) Aminoglycosides of 3,21-dihydroxy-14,21-epoxy-24-nor-cholanic acid and derivatives
IT1207504B (it) Composizione moderatrice dell'appetito ed antigastrica.
DE69002520D1 (de) Azeotropaehnliche zusammensetzungen von 1,1-dichlor-2,2,2-trifluoraethan und 1,1-dochlor-1-fluoraethan.
BR8502769A (pt) Composicao oral,estavel e espumante
PT82554A (en) Process for the preparation of (2,4,5-cis)dioxane and compositions therewith
NZ216113A (en) 2,4,5-substituted-1,3-dioxanes and pharmaceutical compositions
ZA87873B (en) Substituted diazapines and derivatives thereof useful in the treatment of cardiovascular disorders
MY103584A (en) 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it
JPS6466148A (en) Manufacture of 1,5-diaminoheptanol-6, manufacture and use
EP0274066A3 (en) Benzothiazolones, and their production and use
ZA885123B (en) Pest-combating agents based on derivatives of 2,3-diaminomaleonitrile
EP0258773A3 (en) Benzothiazolones, and their production and use
FI871737A0 (fi) Kraftanlaeggning med foerbraenning i en fluidiserad baedd.
EP0581803A4 (en) COMPOSITIONS AND METHODS FOR TREATING A RANGE OF FAULTS USING ETIANATE AND ITS AGONISTS.
Vukadinovic The" Doppelbegabung" of Hector Berlioz: music and literature

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970612